ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Mental Health
Traumatic Stress widely overlook in health evaluations
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 264710" data-attributes="member: 3"><p><em>"Patients also had “significantly reduced” functional impairment using the Sheehan Disability Scale, with a p-value of 0.0271. MAPS said there were no serious adverse events in either the placebo or on-treatment group.</em></p><p><em></em></p><p><em>In addition, 71.2% of participants who received MDMA-assisted therapy no longer met the diagnostic criteria for PTSD at the end of the study, based on the Clinician-Administered PTSD Scale. That’s in comparison to 47.6% of participants on placebo.</em></p><p><em></em></p><p><em>And 46.2% of patients met the remission criteria in the MDMA-assisted group, compared to 21.4% in the placebo."</em></p><p><em></em></p><p>[URL unfurl="true"]https://endpts.com/maps-plans-for-2023-nda-filing-for-mdma-assisted-therapy-after-second-positive-phiii-trial[/URL]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 264710, member: 3"] [I]"Patients also had “significantly reduced” functional impairment using the Sheehan Disability Scale, with a p-value of 0.0271. MAPS said there were no serious adverse events in either the placebo or on-treatment group. In addition, 71.2% of participants who received MDMA-assisted therapy no longer met the diagnostic criteria for PTSD at the end of the study, based on the Clinician-Administered PTSD Scale. That’s in comparison to 47.6% of participants on placebo. And 46.2% of patients met the remission criteria in the MDMA-assisted group, compared to 21.4% in the placebo." [/I] [URL unfurl="true"]https://endpts.com/maps-plans-for-2023-nda-filing-for-mdma-assisted-therapy-after-second-positive-phiii-trial[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Mental Health
Traumatic Stress widely overlook in health evaluations
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top